N@N

EXACT SCIENCES CORP (NASDAQ:EXAS), Up By 6.44% ($0.37) After BUYINS.NET SqueezeTrigger Report Released on Friday, March 18th 20

^{Published on 2011-03-25 09:02:26 - WOPRAI}
 

March 25, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Friday, March 18th 2011 at 07:16:00 PDT stating that EXACT SCIENCES CORP (NASDAQ:EXAS) was expected to be Up After it crossed above its SqueezeTrigger Price of 5.778 on Friday, March 18th 2011. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=exas&id=154570

From August 2009 to February 2011, an aggregate amount of 56931974 shares of EXAS have been shorted for a total dollar value of $284659870. The EXAS SqueezeTrigger price of $5.778 is the volume weighted average price that all shorts are short in shares of EXAS. There is still approximately $23854221.00 of potential short covering in shares of EXAS.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

EXACT SCIENCES CORP (NASDAQ:EXAS) - Exact Sciences Corporation, a molecular diagnostics company, focuses on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Its non-invasive stool-based DNA (sDNA) screening technology includes proprietary and patented methods that isolate and analyze human deoxyribonucleic acid (DNA) present in stool to screen for the presence of colorectal pre-cancer and cancer. The companys principal product includes ColoSure, a non-invasive stool-based DNA testing service for the detection of colorectal cancer in the average-risk population. Exact Sciences Corporation has a strategic alliance with LabCorp; a collaboration, license, and purchase agreement with Genzyme Corporation; and a licensing and research agreement with the MAYO Foundation for Medical Education and Research. The company was founded in 1995 and is headquartered in Madison, Wisconsin.

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net